OCT for lung transplantation monitoring: quantification of chronic lung allograft dysfunction (CLAD) biomarkers (Conference Presentation)

Geoffrey Hohert; Anthony Lee M.D.; Sylvia Lam; Pierre M. Lane; Calum MacAulay; Stephen Lam M.D.; Roland Nador M.D.; Robert Levy; John English

doi:10.1117/12.2291389

14 March 2018 OCT for lung transplantation monitoring: quantification of chronic lung allograft dysfunction (CLAD) biomarkers (Conference Presentation)

Geoffrey Hohert, Anthony Lee M.D., Sylvia Lam, Pierre M. Lane, Calum MacAulay, Stephen Lam M.D., Roland Nador M.D., Robert Levy, John English

Author Affiliations +

Proceedings Volume 10470, Endoscopic Microscopy XIII; 104700A (2018) https://doi.org/10.1117/12.2291389
Event: SPIE BiOS, 2018, San Francisco, California, United States

Abstract

Chronic Lung Allograft Dysfunction (CLAD) remains a significant cause of morbidity and mortality following lung transplantation. Bronchiolitis obliterans Syndrome (BOS) is a predominant phenotype of CLAD primarily affecting the small and subsequently the large airways leading eventually to graft failure. In addition, the allograft airways are also involved in other types of CLAD such as Restrictive Allograft Syndrome (RAS). Freedom from BOS at five years post-transplant is only approximately 50 % among lung transplant recipients. The diagnosis of CLAD is primarily based on pulmonary function testing and radiographic findings on CT scan. Transbronchial biopsies have a low diagnostic yield due to the multifocal nature of CLAD and the frequent lack of bronchioles in the biopsy specimen. Thus, CLAD is often diagnosed after significant disease progression. We performed endoscopic OCT as a minimally invasive method to identify early CLAD biomarkers. During 65 routine surveillance and event-initiated bronchoscopies of lung transplant recipients at Vancouver General Hospital, OCT imaging was performed prior to acquiring biopsy samples, with multiple 3D volumetric scans taken at locations as close as possible to those biopsied. OCT has the potential to be advantageous over biopsy because multiple airways in the lung can be quickly surveyed. As a first step towards clinical utility we present our methods for quantifying observable biomarkers including luminal size and alveolar density. Ranges of values are established and correlated with airway generation, time since transplant, and infection status.

Conference Presentation

Citation Download Citation

Geoffrey Hohert, Anthony Lee M.D., Sylvia Lam, Pierre M. Lane, Calum MacAulay, Stephen Lam M.D., Roland Nador M.D., Robert Levy, and John English "OCT for lung transplantation monitoring: quantification of chronic lung allograft dysfunction (CLAD) biomarkers (Conference Presentation)", Proc. SPIE 10470, Endoscopic Microscopy XIII, 104700A (14 March 2018); https://doi.org/10.1117/12.2291389

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

Lung

Optical coherence tomography

Biopsy

Transplantation

3D image processing

Bronchoscopy

Computed tomography

Show All Keywords

Keywords/Phrases

Search In:

Publication Years